Neutron

Quick links to important sections

Neutron

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Neutron

Quick Facts

Property Description
Active ingredient Mecobalamin (Methylcobalamin)
Form Solution for injection, Tablets
Pharmacological class Vitamin B12 derivative, Hematopoietic Agent
Common use Supports nerve health and red blood cell production
Origin Naturally occurring coenzyme form

What is Neutron, and What is its Composition?

Neutron is a medicine whose active substance is Mecobalamin, which is chemically defined as Methylcobalamin, the biologically active coenzyme form of Vitamin B12 (Cobalamin). It is generally a single-ingredient product, commercially supplied in several high-level dosage forms, including a solution for injection (ampoules) for parenteral administration and solid tablets for oral or sublingual routes. Pharmacological studies support that the inclusion of Mecobalamin—a naturally occurring form of the vitamin—means the substance is immediately available to participate in key bodily processes without requiring prior metabolic conversion by the body.


What Type of Agent is Mecobalamin Classified As?

Mecobalamin is classified as both an agent for the nervous system and a hematopoietic agent, falling into the broader pharmacological class of a Vitamin B12 derivative. This dual classification reflects the essential physiological roles of B12 in maintaining the integrity of the peripheral and central nervous systems, as well as its involvement in the creation of new blood cells. Clinically, it is recognized for its utility in situations where targeted nerve tissue support is necessary. Unlike generic dietary supplements that often contain less active forms like Cyanocobalamin, Mecobalamin delivers the pre-activated coenzyme, emphasizing its direct support for complex biochemical pathways.


What is the General Purpose of Neutron?

The general purpose of Neutron is to ensure the body has sufficient quantities of the essential Mecobalamin required for critical metabolic functions. By serving as an indispensable coenzyme in key reactions, it supports the fundamental integrity and function of nerve tissue, thereby assisting in nerve regeneration. Additionally, this active ingredient is vital for the necessary synthesis of nucleic acids (DNA) that govern the proper maturation and division of red blood cells. Providing this essential micronutrient helps the body maintain healthy nerve cell function and efficient blood production.

Regulatory References

  1. MedlinePlus

What side effects are possible with Neutron?

Official Adverse Reactions and Safety Profile

The safety profile for Neutron (Mecobalamin) is organized by the official classification of adverse reactions, reflecting patterns documented in governmental regulatory sources. Adverse reactions are grouped according to the body system affected, known as System-Organ Classes.


Documented System-Organ Classes and Frequency

Side effects documented in regulatory labeling primarily fall into three main categories. Those classified as Rare in official reports include Anorexia (loss of appetite), Nausea, Vomiting, and Diarrhea, which may occur during oral administration. More frequently reported, or More Commonly Occurring, adverse effects include Headache, Sweating, and a Hot sensation.

System-Organ Class Documented Reactions Frequency Note
Gastrointestinal Disorders Upset stomach, Nausea, Vomiting, Diarrhea Rare
Immune / Skin Disorders Hypersensitivity, Allergic reaction, Rash, Sweating More Commonly Occurring
Nervous System Disorders Headache More Commonly Occurring

Serious Adverse Reactions

The regulatory profile documents rare but serious adverse reactions, which are primarily associated with the injectable form of B12 derivatives. These include events such as Anaphylactic Shock, a severe systemic allergic reaction, Pulmonary Edema (fluid in the lungs), and Congestive Heart Failure.


Population-Specific Safety Considerations and Restrictions

The official label contains specific safety notes for certain patient groups. For Older Adults, the label notes the potential for reduced intestinal absorption of the substance. For those with Hepatic Impairment, the medicine may affect the liver and requires explicit consideration. Safety is also addressed for individuals with known Cobalt allergy, which necessitates vigilance for sensitivity reactions. Use is officially restricted or advised against in the presence of Leber's disease and any known Hypersensitivity to Mecobalamin or its components.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation for Neutron (Mecobalamin) indicates a low potential for toxicity due to its nature as a water-soluble vitamin derivative. This means severe or life-threatening systemic outcomes resulting directly from an overdose are generally not documented or anticipated, even at high doses.

Documented Manifestations and Actions

Domain Official Regulatory Summary
Documented Manifestations No specific or serious overdose symptoms are typically listed in official labeling; excess compound is efficiently excreted.
Antidote Information No specific antidote is known for Mecobalamin overdose.
Supportive Management Overdose management is officially defined as symptomatic and supportive treatment.

When to Seek Urgent Medical Help

Regulatory authorities mandate that individuals must seek immediate medical attention for any suspected overdose of Neutron. This action is required regardless of the low toxic potential. In the event of suspected overdosage, medical professionals should be contacted immediately for guidance, as management is restricted to supportive care based on the patient's clinical state. Clinical observation may be necessary, but this decision is made by medical staff.

Therapeutic Uses of Neutron

What Neutron Treats: Main Uses and Benefits

The use of Neutron is relevant in symptomatic management to help provide temporary, supportive relief across various symptomatic domains, particularly those associated with discomfort and episodic patterns. The therapeutic domains generally cover conditions presenting with heightened symptoms, fluctuating manifestations, and instances where short-term symptomatic assistance is needed.

Supporting Symptomatic Discomfort and Acute Episodes

Neutron is commonly used in situations involving certain distressing symptoms that may appear suddenly or intensify over time. This medicine is considered relevant in contexts where additional symptomatic support is needed, and provides support that helps ease the overall symptom burden. Supportive care often focuses on symptoms associated with distress.

Managing Episodic or Fluctuating Symptom Patterns

This medicine is applied across conditions characterized by periods of heightened symptoms or episodic or fluctuating manifestations, such as conditions associated with acute or disruptive episodes. It helps address symptom clusters that create noticeable functional strain, and assists with maintaining functional stability during phases when symptoms become more disruptive or noticeable.

Temporary Assistance for Heightened Distress

Neutron is helpful in situations requiring short-term symptomatic assistance, often used during phases of increased distress or discomfort. It contributes to improved comfort during symptomatic periods, and may help patients cope more steadily with symptom fluctuations. “The support offered by this medicine helps when symptoms momentarily feel overwhelming.”


Quick Fact: Supports patients during episodes of heightened discomfort


Regulatory References

  1. NHS guidance on managing stress and feeling overwhelmed

Eligibility and Restrictions for Use

Population Eligibility and Contraindications

The official regulatory profile for Neutron (Mecobalamin) defines strict rules for who can and cannot use the medicine, based on population characteristics and pre-existing conditions.

Absolute Contraindications

The medicine is contraindicated (must not be used) in patients with a confirmed hypersensitivity (allergy) to Methylcobalamin, Cobalt, or any component of the product. Use is also strictly prohibited for individuals diagnosed with Leber's disease (hereditary optic nerve atrophy).

Conditional Use and Restrictions

Use is conditional and requires caution in patients with impaired kidney function (renal impairment) due to the risk of aluminum accumulation from some formulations. Caution is also advised for those with liver disease (hepatic impairment). The medicine's therapeutic response may be impeded by concurrent conditions such as serious infection or undiagnosed folic acid or iron deficiency.

Age-Specific Rules

General pediatric use is not recommended, and safety has not been established in children under 11 years. Certain formulations are contraindicated in premature neonates. Older adults require conservative dose selection due to common age-related decline in organ function.

Reproductive Status

While use is required to correct documented deficiency during pregnancy, some guidance restricts arbitrary use after the first trimester. The medicine is generally found to be safe for use while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Neutron (Mecobalamin) details interactions that primarily involve reduced absorption and pharmacodynamic masking, rather than complex enzymatic or transporter-mediated effects.

Pharmacokinetic Interactions: Reduced Exposure

Several medicinal products are officially documented to cause a pharmacokinetic interaction by leading to a reduction in Mecobalamin's gastrointestinal absorption, resulting in lower plasma exposure. This class of interaction includes: Antacids and acid-reducing agents (such as H2 blockers and Proton Pump Inhibitors), which interfere with the gastric acidity required for B12 release. Other specific agents documented to reduce absorption include Metformin, Aminosalicylic acid, Neomycin, Colchicine, and Cholestyramine.

Pharmacodynamic and Substance Interactions

Co-administration with Folic acid is a documented pharmacodynamic interaction risk, as high doses may mask the hematological symptoms of B12 deficiency without addressing the potential progression of neurological manifestations. Furthermore, the regulatory labels cite that heavy, chronic consumption of alcohol officially interferes with Mecobalamin absorption. Limited reports also indicate that Chloramphenicol may delay or interrupt the reticulocyte response to Mecobalamin supplementation.

Interaction-Related Restriction

The use of Mecobalamin is a formal restriction in patients with Leber's disease (hereditary optic nerve atrophy) due to the documented risk of worsening the condition.

Mechanism of Action

Neutron's active ingredient, Mecobalamin, functions as an essential coenzyme, directly facilitating the activity of two critical metabolic enzymes: Methionine Synthase and L-Methylmalonyl-CoA Mutase. This role is central to the One-Carbon Metabolism cycle, where Mecobalamin acts as a methyl group donor to facilitate the conversion of substrates like Homocysteine and Methylmalonyl-CoA into required metabolic products. By completing these reactions, the mechanism maintains necessary metabolic flux and limits the accumulation of certain metabolites.

The enzymatic conversion catalyzed by Mecobalamin generates S-adenosylmethionine (SAMe), a molecule vital for the myelinogenesis pathway. This cascade is required for the ongoing methylation of structural phospholipids essential for the structural integrity of the myelin sheath, which aids the transmission of nerve signals. Mecobalamin's action is also critical for regenerating tetrahydrofolate ( THF), which is necessary for the synthesis of DNA components. This effect is essential for the mitotic division and maturation of rapidly multiplying cells in the bone marrow, contributing to successful erythropoiesis.

Dosage and Administration Information

Neutron (Mecobalamin) is administered via both parenteral (injection) and oral routes, reflecting its availability as an injectable solution and as tablets. The method of administration is typically guided by the need to bypass or utilize the digestive system. Intramuscular (IM) and intravenous (IV) injections are indicated for use, particularly when a patient has impaired intestinal absorption.

The official use protocol is structured in two distinct phases. Treatment begins with a short-term, high-frequency loading phase. During this initial period, parenteral doses commonly range from 500 mcg to 1,000 mcg, often given daily or on alternate days until the body’s reserves are saturated.

Following the loading period, the regimen transitions to a long-term maintenance phase that may continue indefinitely. Parenteral frequency is significantly reduced, often to a maintenance dose of 500 mcg to 1,000 mcg given at intervals of one to three months. Alternatively, high-dose oral administration, typically 1,000 mcg to 2,000 mcg daily, may be used for long-term maintenance. Dosage may be adjusted according to the patient's age and oral tablets are sometimes directed to be taken with a meal.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Neutron


Evidence for Use in Nerve Health and Function

The research examined the use of Mecobalamin (Neutron) in individuals with peripheral neuropathy, including that associated with diabetes. This research primarily involves short-term Randomized Controlled Trials (RCTs) and systematic reviews. Researchers examined patient-reported outcomes to assess outcomes related to physical discomfort, such as tingling, numbness, and pain intensity. They also monitored objective measures, like changes in the speed and strength of nerve signals (nerve conduction velocity).

Studies reported measurements of changes in self-reported symptom scores during the study period. However, the data show patterns related to mixed findings when comparing these symptomatic measurements to the objective changes observed in nerve conduction tests. Systematic reviews noted that many of the original studies had modest sample sizes and the evidence quality varies across studies.


Evidence for Correction of Vitamin B12 Deficiency

Mecobalamin was extensively evaluated in the context of systemic or functional imbalance caused by confirmed Vitamin B12 deficiency. The evidence base for correcting B12 deficiency is well-established. These studies tracked the body's response to the vitamin replacement, monitoring biochemical parameters (like B12 levels) and hematological parameters (related to red blood cell health).

Findings describe group patterns where resolution or stabilization of symptoms was observed in populations receiving replacement therapy. This evidence contributes to understanding symptom patterns by documenting the timeline for the resolution of deficiency-related neurological and systemic outcomes.


What Is Still Uncertain About Neutron Research

For nerve-related research, follow-up durations were limited, often not extending beyond six months. This means that long-term effects are not fully established, and there is limited information regarding the sustained changes or durability of symptomatic patterns. The research is ongoing in its supportive role for chronic nerve conditions. Comparative evidence is lacking regarding the long-term outcomes when using Mecobalamin versus other commercially available forms of Vitamin B12 in non-deficient individuals. Certainty remains low in establishing a consistent role beyond the correction of deficiency.

Key Studies & References

  1. Clinical efficacy of methylcobalamin in treating diabetic peripheral neuropathy: a randomized, double-blind, parallel-group, comparative study

Frequently Asked Questions (FAQ)

Common questions about Neutron (FAQ)


Q: Do I have to take Neutron at a specific time of day?

A: Official labeling for the oral tablet form sometimes indicates the medicine may be taken with a meal. While the recommended daily frequency is often divided into multiple doses, regulatory guidance typically does not specify one mandatory time of day for administration. Information regarding the most appropriate timing should be clarified with the healthcare professional providing the prescription.

Q: How long does it usually take for Neutron to start working?

A: In cases where Neutron is used to correct a Vitamin B12 deficiency, the therapeutic response, including the resolution of deficiency-related systemic symptoms, is described in evidence as being well-established and generally observed within a reasonable timeframe. However, for nerve-related support in other conditions, research follow-up durations were often limited, and information on the exact timeline for sustained effects is less clearly documented.

Q: What should I do if I forget to take my Neutron dose?

A: The procedures for handling a missed dose are typically detailed in the official patient information leaflet and vary based on the specific regimen. This information includes guidance on when to skip a dose versus when it may be appropriate to take it. These specific instructions should be reviewed with a qualified healthcare provider.

Q: Can Neutron affect my ability to drive or operate machinery?

A: The official safety profile lists side effects such as Headache and a Hot sensation as commonly occurring reactions. While regulatory summaries may not explicitly restrict driving, it is generally recommended that individuals exercise caution and understand their response to the medicine before driving or operating complex machinery.

Q: Is it safe to drink alcohol while taking Neutron?

A: Official documents cite that heavy, chronic consumption of alcohol is known to interfere with the body's ability to absorb Mecobalamin, potentially resulting in lower levels of the substance. Consultation with a healthcare provider is recommended regarding any level of alcohol consumption during the course of therapy.

Q: Can I take Neutron if I am pregnant or planning to be?

A: If a documented B12 deficiency exists, use during pregnancy is often required to correct it. However, some regulatory guidance advises restricting arbitrary use of the vitamin after the first trimester. Official information indicates the medicine is generally considered safe for use while breastfeeding. The decision to use this medicine during pregnancy or when planning pregnancy should be reviewed with the prescribing physician.

Q: Can older adults use Neutron safely?

A: Regulatory documents note that older adults may experience reduced intestinal absorption of Mecobalamin, and require careful, conservative dose selection due to common age-related declines in organ function. Caution is generally advised for this population, and the selection of an appropriate dose is recommended.

Q: Can Neutron be taken with daily vitamins or supplements?

A: A specific, documented risk involves high doses of Folic acid, which may mask important symptoms of B12 deficiency. Official sources recommend disclosing all medicines and supplements, including daily vitamins and herbal remedies, to the prescribing medical practitioner to help avoid potential issues.

Q: Is it common to feel tired when first starting Neutron?

A: Tiredness or fatigue is not explicitly listed among the commonly reported side effects in the official safety profile. Fatigue is a known symptom of Vitamin B12 deficiency, a condition for which the medicine is often prescribed.

Q: Is there a generic version of Neutron available?

A: Yes, the active substance, Mecobalamin (Methylcobalamin), is widely listed in regulatory databases as an ingredient. This means that generic formulations of Methylcobalamin, such as injections or tablets, are available commercially, in addition to the brand-name product.

Q: Is Neutron considered a controlled substance?

A: Neutron, whose active ingredient is Mecobalamin (Vitamin B12), is officially classified as a vitamin. Because of this classification, the substance is not listed as a controlled substance under regulatory acts like the U.S. Controlled Substances Act (CSA) or similar international frameworks.

Q: How does Neutron show up in a drug screening?

A: Mecobalamin is a vitamin and would not typically be included in standard drug screenings used to detect controlled or illicit substances. However, the substance is involved in key bodily processes, and medical tests may monitor metabolites (chemical byproducts) like methylmalonic acid to assess your overall B12 status.

Q: Can I stop taking Neutron suddenly, or do I need to taper off?

A: Official guidance often advises against stopping treatment with B12 derivatives unless specifically instructed to do so by a healthcare provider. For certain chronic conditions treated by Neutron, therapy is typically required long-term. You should consult your doctor before making any change to your regimen.

Q: How long does Neutron stay in your system after you stop taking it?

A: Pharmacokinetic data indicates that the active substance has an elimination half-life of approximately 6 days in the bloodstream. However, the body is capable of storing large amounts of the substance in the liver for much longer periods, where it is released slowly over time.

Q: Does the efficacy of Neutron decrease over time (tolerance)?

A: Regulatory documents and clinical summaries do not explicitly describe the development of tolerance to Mecobalamin over time. However, official warnings note that effectiveness can be impaired or reduced by other issues, such as co-administered medications (e.g., Chloramphenicol) or an undiagnosed iron deficiency.

Q: What is the risk of dependence or addiction with Neutron?

A: Since Mecobalamin is not classified as a controlled substance, the official regulatory sections dedicated to 'Drug Abuse and Dependence' generally do not list a risk of physical dependence or addiction associated with its use.

Q: Why do some people say they feel anxious after starting Neutron?

A: While anxiety is not listed as a common side effect of the oral form, regulatory documentation for the injectable form of Vitamin B12 has reported events such as anxiety and nervousness. If these feelings are experienced, communication with a healthcare provider is recommended.

Q: Is it normal to have mild headaches when adjusting to Neutron?

A: Headache is listed in the official safety profile as a More Commonly Occurring adverse effect. If headaches are persistent or severe, consultation with a healthcare provider is recommended.

Q: Does Neutron affect birth control pills?

A: Regulatory databases that summarize drug interactions for Vitamin B12 compounds typically indicate no known interactions between B12 and common oral contraceptive agents. Disclosure of all co-administered medications, including birth control, to a healthcare provider is always recommended.

Q: Is it possible to become resistant to the effects of Neutron?

A: Official warnings note that an inadequate response to the medicine's effects may occur due to external factors, such as the presence of a serious infection or an undiagnosed deficiency of iron or folic acid. This indicates external interference with effectiveness, rather than the development of resistance to the substance itself.

How should Neutron be stored and disposed of?

How to Store and Dispose of Neutron

Official regulatory guidelines define specific conditions for storing and disposing of Neutron (Mecobalamin) to maintain product stability and safety.


Storage Requirements

  • Temperature: Store at Controlled Room Temperature, typically 20^circC to 25^circC (68^circF to 77^circF).
  • Protection: The medicine must be protected from light and should not be frozen. Keep the product in its original container to maintain integrity.
  • Child Safety: It is mandatory to keep the medicine out of the sight and reach of children.

Disposal Instructions

Unused or expired Neutron must be disposed of according to local pharmaceutical waste requirements; it should not be flushed down a drain or placed in household trash. Used needles and syringes from the injection form must be discarded as sharps waste in a designated puncture-proof container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Neutron found in:

A-Z Index: